Stockholder's Equity

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

Stockholder's Equity

NOTE 3 – STOCKHOLDER’S EQUITY

In January 2016 the Company issued 25,000,000 shares of common stock to Chong Corporation, a related entity, in exchange for five exclusive, worldwide license agreements. We issued 5,000,000 shares for each of the license agreements, for an aggregate issuance of 25,000,000 shares. In accordance with GAAP, the intellectual property is carried on the VapAria balance sheet at a fair value of $100,772. The five license agreements are as follows:

U.S. Patent No.: 8,903228 issued on December 20, 2014 for a vapor delivery device;

U.S. Patent No.: 8,962,040 issued on February 24, 2015 for vaporized appetite suppression (hoodia);

U.S. Patent No.: 9,254,002 issued on February 9, 2016- for vaporization of a tobacco formulation;

U.S. Patent No.: 9,283,180 issued on March 15, 2016- for a vaporized sleep aid- LTV-(melatonin); and

U.S. Patent App. No.: 13/453,939 filed on April 12, 2012 for an enhanced vapor delivery system.

On May 23, 2016 the Company paid an annual dividend of 50,000 shares of common stock to the sole shareholder of our Series A Preferred Stock, Chong Corporation, a related party.

On July 26, 2016, the United States Patent and Trademark Office issued US Patent No.: 9,399,110 related to US Patent Application No.: 13/453,939 filed on April 12, 2012 for an enhanced vapor delivery system. The issuance of this patent means that the entire IP portfolio licensed by the Company in the January 2016 license agreement, which then included a total of four patents and one patent application, is now five patents.

On September 30, 2016, the Company had 75,210,000 shares of common stock issued and outstanding.